SCHEMBL8286166

SCHEMBL8286166

CC(C)(C)Oc1cncc2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 5/20 0.37
HPGD P15428 3/20 0.37
MAPK1 P28482 1/20 0.37
PDE11A Q9HCR9 1/20 0.36
GSK3B P49841 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
CDK4 P11802 1/20 0.33
CCND1 P24385 1/20 0.33
CCND2 P30279 1/20 0.33
CCND3 P30281 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
BUB1 O43683 1/20 0.33
MAPK13 O15264 4/20 0.32
MAPK12 P53778 4/20 0.32
MAPK11 Q15759 4/20 0.32
MAPK14 Q16539 4/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286163 0.89 BRAF (0.40) GAAHPGDMAPK1PDE11AGSK3B
SCHEMBL8286161 0.85 CYP1A2 (0.36) GAAHPGDMAPK1PDE11AGSK3B
SCHEMBL5872272 0.82 GAA (0.38) GAAHPGDMAPK1PDE11AGSK3B
SCHEMBL8287214 0.82 GAA (0.44) GAAHPGDMAPK1PDE11AGSK3B
SCHEMBL8287246 0.81 GAA (0.39) GAAHPGDMAPK1PDE11AGSK3B
SCHEMBL8287268 0.81 GAA (0.38) GAAHPGDMAPK1PDE11AGSK3B
SCHEMBL8287501 0.81 GAA (0.39) GAAHPGDMAPK1PDE11AGSK3B
SCHEMBL8286454 0.80 GAA (0.38) GAAHPGDMAPK1PDE11AGSK3B
SCHEMBL8287281 0.80 GAA (0.38) GAAHPGDMAPK1PDE11AGSK3B
SCHEMBL8286488 0.80 GAA (0.39) GAAHPGDMAPK1PDE11AGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed